Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Ceftriaxone
Drug ID BADD_D00405
Description Ceftriaxone is a broad-spectrum third-generation cephalosporin antibiotic.[A215582] It has a very long half-life compared to other cephalosporins and is high penetrable into the meninges[A215582], eyes[A215647], and inner ear[A215627]. Ceftriaxone has broader and stronger gram-negative coverage then first or second-generation cephalosporins, but worse activity against methicillin-susceptible S.aureus. Ceftriaxone is a commonly used antimicrobial due to its good activity against multi-drug resistant Enterobacteriaceae, its relatively safe adverse effect profile, and its long half-life which allows for the convenience of daily or twice-daily dosing.[A215582]
Indications and Usage Ceftriaxone is used for the treatment of the infections (respiratory, skin, soft tissue, UTI, ENT) caused by susceptible organisms.[L15082] Organisms that are generally susceptible to ceftriaxone include S. pneumoniae, S. pyogenes (group A beta-hemolytic streptococci), coagulase-negative staphylococci, Some Enterobacter spp, H. influenzae, N. gonorrhoeae, P. mirabilis, E. coli, Klebsiella spp, M. catarrhalis, B. burgdorferi, and some oral anaerobes.[A215582]
Marketing Status approved
ATC Code J01DD04
DrugBank ID DB01212
KEGG ID D07659
MeSH ID D002443
PubChem ID 5479530
TTD Drug ID D07ACT
NDC Product Code 72572-061; 25021-105; 25021-107; 44567-700; 63323-346; 0143-9859; 66794-213; 71205-593; 72572-062; 66794-215; 70594-098; 44567-701; 66794-211; 70518-3355; 25021-106; 0143-9856; 44567-702; 66794-214; 70594-094; 70594-097; 0264-3155; 66794-212; 44567-703; 0264-3153; 70594-095; 70594-096; 0143-9678; 0143-9857; 0143-9858
UNII 75J73V1629
Synonyms Ceftriaxone | Ceftriaxon | Cefatriaxone | Ceftriaxone, Disodium Salt, Hemiheptahydrate | Ceftrex | Ceftriaxon Curamed | Ceftriaxon Hexal | Ceftriaxona Andreu | Ceftriaxona LDP Torlan | Ceftriaxone Irex | Ceftriaxone Sodium | Ceftriaxone Sodium, Anhydrous | Anhydrous Ceftriaxone Sodium | Lendacin | Longacef | Longaceph | Ro13-9904 | Ro13 9904 | Ro139904 | Ro-13-9904 | Ro 13-9904 | Ro 13 9904 | Ro 139904 | Rocephin | Rocefalin | Rocephine | Rocefin | Tacex | Terbac | Ceftriaxone, Disodium Salt | Benaxona | Cefaxona
Chemical Information
Molecular Formula C18H18N8O7S3
CAS Registry Number 73384-59-5
SMILES CN1C(=NC(=O)C(=O)N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Feeling hot08.01.09.009--Not Available
Flank pain20.02.03.006; 15.03.04.003; 08.01.08.0070.086903%
Flatulence07.01.04.002--
Flushing24.03.01.002; 23.06.05.003; 08.01.03.0250.020054%
Foetal distress syndrome18.03.02.0030.011141%Not Available
Fungal infection11.03.05.001--Not Available
Gastrointestinal pain07.01.05.005--
Generalised oedema14.05.06.007; 08.01.07.0040.004457%
Generalised tonic-clonic seizure17.12.01.0020.013370%Not Available
Gingival bleeding24.07.02.010; 07.09.07.0010.008913%Not Available
Glossitis07.14.01.001--Not Available
Glossodynia07.14.02.001--Not Available
Glycosuria20.02.01.005--
Guillain-Barre syndrome17.09.01.001; 10.04.10.005; 11.07.01.0010.004457%
Haematocrit decreased13.01.05.001--Not Available
Haematuria21.10.01.018; 24.07.01.047; 20.02.01.0060.020054%
Blood urine present13.13.02.002--Not Available
Haemoglobin13.01.05.018--Not Available
Haemolysis01.06.04.0020.031196%
Haemolytic anaemia01.06.03.0020.091359%Not Available
Headache17.14.01.001--
Henoch-Schonlein purpura01.01.04.001; 24.07.06.003; 23.06.01.002; 10.02.02.0040.006685%Not Available
Hepatic encephalopathy09.01.03.006; 17.13.01.0030.004457%Not Available
Hepatic function abnormal09.01.02.0010.027631%Not Available
Hepatitis09.01.07.0040.060163%Not Available
Hepatitis acute09.01.07.0050.015598%Not Available
Hepatitis cholestatic09.01.01.0020.017826%Not Available
Hepatocellular injury09.01.07.0080.017826%Not Available
Hepatotoxicity12.03.01.008; 09.01.07.0090.013370%Not Available
Hydronephrosis20.01.05.0010.198316%Not Available
The 5th Page    First    Pre   5 6 7 8 9    Next   Last    Total 16 Pages